Clinical trial
An Observational Study of the Safety of Topiramate in Adults and Children With…
NCT00297323 · Janssen Cilag Pharmaceutica S.A.C.I., Greece, Industry · Completed
Key facts
| NCT number | NCT00297323 |
|---|---|
| Title | An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy |
| Official title | An Open Observational Safety Study During Administration of Topamac, as Monotherapy in Epileptic Patients With no Prior Treatment or Unsuccessfully Treated With Other Antiepileptic Drug |
| Lead sponsor | Janssen Cilag Pharmaceutica S.A.C.I., Greece, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Seizures, Epileptic |
| Intervention type | Drug |
| Interventions | Topiramate |
| Enrollment | 80 |
| Start date | Jun 1, 2005 |
| Completion | Feb 1, 2007 |
| First posted | Feb 28, 2006 |
| Last update posted | Apr 27, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: